Search results for "genetic markers"

showing 10 items of 197 documents

Genetic variability at neutral markers, quantitative trait loci and trait in a subdivided population under selection

2003

Abstract Genetic variability in a subdivided population under stabilizing and diversifying selection was investigated at three levels: neutral markers, QTL coding for a trait, and the trait itself. A quantitative model with additive effects was used to link genotypes to phenotypes. No physical linkage was introduced. Using an analytical approach, we compared the diversity within deme (HS) and the differentiation (FST) at the QTL with the genetic variance within deme (VW) and the differentiation (QST) for the trait. The difference between FST and QST was shown to depend on the relative amounts of covariance between QTL within and between demes. Simulations were used to study the effect of se…

Genetic Markers0106 biological sciencesGenotypeQuantitative Trait LociPopulation[SDV.GEN] Life Sciences [q-bio]/GeneticsQuantitative trait locusBiology010603 evolutionary biology01 natural sciences03 medical and health sciencesFamily-based QTL mappingGeneticsComputer SimulationGenetic variabilitySelection Genetic10. No inequalityeducationSelection (genetic algorithm)ComputingMilieux_MISCELLANEOUS030304 developmental biologyDemeGenetics0303 health scienceseducation.field_of_study[SDV.GEN]Life Sciences [q-bio]/GeneticsModels GeneticDisruptive selectionGenetic VariationGenetic architectureGenetics PopulationPhenotypeEvolutionary biologyResearch Article
researchProduct

Genetic diversity and trait genomic prediction in a pea diversity panel

2014

Background Pea (Pisum sativum L.), a major pulse crop grown for its protein-rich seeds, is an important component of agroecological cropping systems in diverse regions of the world. New breeding challenges imposed by global climate change and new regulations urge pea breeders to undertake more efficient methods of selection and better take advantage of the large genetic diversity present in the Pisum sativum genepool. Diversity studies conducted so far in pea used Simple Sequence Repeat (SSR) and Retrotransposon Based Insertion Polymorphism (RBIP) markers. Recently, SNP marker panels have been developed that will be useful for genetic diversity assessment and marker-assisted selection. Resu…

Genetic Markers0106 biological sciencesGenotype[SDV]Life Sciences [q-bio]Best linear unbiased predictionBiologyPolymorphism Single Nucleotide01 natural sciences03 medical and health sciencesSativumGenetic variationGenetics[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyLeast-Squares Analysis030304 developmental biology2. Zero hungerPrincipal Component Analysis0303 health sciencesGenetic diversitybusiness.industryPeasDiscriminant AnalysisGenetic Variationfood and beveragesBayes Theorem15. Life on landMarker-assisted selectionBiotechnologyPhenotype13. Climate actionEvolutionary biologyGenetic marker[SDE]Environmental SciencesLinear ModelsTraitRate of evolutionbusinessGenome PlantMicrosatellite RepeatsResearch Article010606 plant biology & botanyBiotechnology
researchProduct

Development and implementation of high-throughput SNP genotyping in barley

2009

Abstract Background High density genetic maps of plants have, nearly without exception, made use of marker datasets containing missing or questionable genotype calls derived from a variety of genic and non-genic or anonymous markers, and been presented as a single linear order of genetic loci for each linkage group. The consequences of missing or erroneous data include falsely separated markers, expansion of cM distances and incorrect marker order. These imperfections are amplified in consensus maps and problematic when fine resolution is critical including comparative genome analyses and map-based cloning. Here we provide a new paradigm, a high-density consensus genetic map of barley based…

Genetic Markers0106 biological sciencesGenotypelcsh:QH426-470Genetic Linkagelcsh:BiotechnologyPopulationSingle-nucleotide polymorphismBiologyPolymorphism Single Nucleotide01 natural sciences03 medical and health sciencesGene mappinglcsh:TP248.13-248.65Research articleGeneticseducationAlleles030304 developmental biology2. Zero hungerGenetics0303 health scienceseducation.field_of_studyfood and beveragesHordeumSNP genotypingMinor allele frequencylcsh:GeneticsGenetic TechniquesGenetic distanceGenetic markerDoubled haploidy010606 plant biology & botanyBiotechnology
researchProduct

Using genetic markers to unravel the origin of birds converging towards pre-migratory sites

2018

AbstractIdentifying patterns of individual movements in spatial and temporal scales can provide valuable insight into the structure of populations and the dynamics of communities and ecosystems. Especially for migrating birds, that can face a variety of unfavorable conditions along their journey, resolving movements of individuals across their annual cycle is necessary in order to design better targeted conservation strategies. Here, we studied the movements of a small migratory falcon, the Lesser Kestrel (Falco naumanni), by genetically assigning feathers from individuals of unknown origin that concentrate in large roosts during the pre-migratory period. Our findings suggest that birds fro…

Genetic Markers0106 biological sciencesPopulation DynamicsSettore BIO/05 - Zoologialcsh:MedicineKestrellesser kestrel pre-migratory stage microsatellites genetic of migrationBreeding010603 evolutionary biology01 natural sciencesArticle010605 ornithologyBirdsSexual Behavior AnimalAnimalsEcosystem14. Life underwaterlcsh:ScienceTemporal scalesEcosystemFalconiformesMultidisciplinarybiologyMediterranean RegionEcologylcsh:RFalco naumanniBalkan Peninsula15. Life on landbiology.organism_classificationEastern mediterraneanGeographyGenetic markerAnimal Migrationlcsh:QOrigin of birdsSeasonsScientific Reports
researchProduct

Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives

2016

The new therapeutic approach of using immune checkpoint inhibitors as anticancer agents is a landmark innovation. Early studies suggest that immune checkpoint inhibition might also be effective in patients with gastrointestinal cancer. To improve the efficacy of immunotherapy, different strategies are currently under evaluation. This review summarises the discussion during the European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Translational Research Meeting in Mainz in November 2014 and provides an update on the most recent results of immune therapy in gastrointestinal cancers. Knowledge of potential relationships between tumour cells and their microenv…

Genetic Markers0301 basic medicineCancer Researchmedicine.medical_treatmentAntineoplastic AgentsTranslational researchContext (language use)Antibodies Monoclonal Humanized03 medical and health sciencesGastrointestinal cancer0302 clinical medicineImmune systemBiomarkers TumormedicineHumansMolecular Targeted TherapyGastrointestinal cancerGastrointestinal NeoplasmsOncolytic Virotherapybusiness.industryCancerCell Cycle CheckpointsImmunotherapymedicine.diseaseImmune checkpointOncolytic virusTreatment Outcome030104 developmental biologyOncology030220 oncology & carcinogenesisImmunologyCancer researchImmunotherapyEpidemiologic MethodsbusinessCheckpoint inhibitorsForecastingEuropean Journal of Cancer
researchProduct

Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory

2017

Epigenetic modifications and regulators represent potential molecular elements which control relevant physiological and pathological features, thereby contributing to the natural history of human disease. These epigenetic modulators can be employed as disease biomarkers, since they show several advantages and provide information about gene function, thus explaining differences among patient endophenotypes. In addition, epigenetic biomarkers can incorporate information regarding the effects of the environment and lifestyle on health and disease, and monitor the effect of applied therapies. Technologies used to analyze these epigenetic biomarkers are constantly improving, becoming much easier…

Genetic Markers0301 basic medicineEpigenetic biomarkersComputer scienceBiochemistry (medical)Clinical BiochemistryGenomicsGenomicsDiseaseDNA MethylationPrecision medicineClinical routineArticleGeneral Biochemistry Genetics and Molecular BiologyEpigenesis Genetic03 medical and health sciences030104 developmental biologyMolecular Diagnostic TechniquesRisk analysis (engineering)HumansBiomarker (medicine)Disease biomarkerEpigeneticsCritical Reviews in Clinical Laboratory Sciences
researchProduct

Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis

2018

Psoriatic plaques tend to localize to the knees and elbows, areas that are particularly subject to mechanical stress resulting from bending and friction. Moreover, plaques often develop at sites of mechanical trauma or injury (Koebner phenomenon). Nevertheless, mechanotransduction has never been linked to psoriasis. Polycystins (polycystin-1, PC1; polycystin-2, PC2) are mechanosensitive molecules that function as key regulators of cellular mechanosensitivity and mechanotransduction. The aim of this in vitro study was to investigate the role of polycystins in the development of psoriasis. We showed that PC1 knockdown in HaCaT cells led to an elevated mRNA expression of psoriasis-related biom…

Genetic Markers0301 basic medicineMAPK/ERK pathwayendocrine systemTRPP Cation ChannelsMAP Kinase Signaling SystemDown-RegulationModels BiologicalCell Line03 medical and health sciences0302 clinical medicineDownregulation and upregulationCell MovementPsoriasismedicineHumansPsoriasisMechanotransductionMolecular BiologyPI3K/AKT/mTOR pathwayCell ProliferationGene knockdownCell growthChemistryTOR Serine-Threonine Kinasesmedicine.diseaseCell biologyHaCaT030104 developmental biologyGene Knockdown Techniques030220 oncology & carcinogenesisMolecular MedicineBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
researchProduct

Replication of linkage of familial hypobetalipoproteinemia to chromosome 3p in six kindreds

2002

Familial hypobetalipoproteinemia (FHBL) is a genetically heterogeneous condition characterized by very low apolipoprotein B (apoB) concentrations in plasma and/or low levels of LDL-cholesterol (LDL-C) with a propensity to developing fatty liver. In a minority of cases, truncation-specifying mutations of the apoB gene (APOB) are etiologic, but the genetic basis of most cases is unknown. We previously reported linkage of FHBL to a 10 cM region on 3p21.1-22 in one kindred. The objectives of the current study were to identify other FHBL families with linkage to 3p and to narrow the FHBL susceptibility region on 3p. Six additional FHBL kindreds unlinked to the APOB region on chromosome 2 were ge…

Genetic MarkersAdultMaleMeiosiSettore MED/09 - Medicina InternaApolipoprotein BGenotypeGenetic LinkageQD415-436BiologyBiochemistryChromosomal crossoverHypobetalipoproteinemiasEndocrinologyQuantitative Trait HeritableGenetic linkageGenetic MarkerHaplotypeHumanslinkage analysisCrossing Over GeneticChildAgedAdult; Aged; Aged 80 and over; Child; Chromosome Mapping; Chromosomes Human Pair 3; Crossing Over Genetic; Female; Genetic Linkage; Genetic Markers; Genotype; Haplotypes; Humans; Hypobetalipoproteinemias; Male; Meiosis; Middle Aged; Pedigree; Quantitative Trait HeritableGeneticsAged 80 and overGenetic heterogeneityHaplotypeChromosomeChromosome MappingCell BiologyoligogenicMiddle AgedPedigreeMeiosisMarkov chain Monte CarloChromosome 3HaplotypesGenetic markerbiology.proteinvariance componentslipids (amino acids peptides and proteins)FemaleChromosomes Human Pair 3geneticHypobetalipoproteinemiaHuman
researchProduct

Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer.

2005

Cancer/germline (CG) antigens represent promising targets for widely applicable mono- and multiantigen cancer vaccines for nonsmall cell lung cancer (NSCLC). Since little is known about their composite expression in this tumor type, we analyzed 7 CG genes (MAGE-A3, NY-ESO-1, LAGE-1, BRDT, HOM-TES-85, TPX-1 and LDHC) in 102 human NSCLC specimens. About 81% of NSCLC express at least 1 and half of the specimen at least 2 CG genes. Activation of most of these genes occurs more frequently in squamous cell cancer than in adenocarcinomas. Even though we found all genes but one to be regulated by genomic methylation, not all of them are co-expressed. In particular, combining CG genes not localized …

Genetic MarkersCancer ResearchLung Neoplasms/geneticsLung NeoplasmsBiologyGermlineEpigenesis GeneticGermline mutationAntigens NeoplasmCarcinoma Non-Small-Cell Lung/geneticsCarcinoma Non-Small-Cell LungmedicineTumor Cells CulturedHumansGeneGerm-Line MutationGene Expression ProfilingCancerMethylationDNA Methylationmedicine.diseaseGene expression profilingOncologyDNA methylationImmunologyCancer researchCancer/testis antigensInternational journal of cancer
researchProduct

MGFM: a novel tool for detection of tissue and cell specific marker genes from microarray gene expression data

2015

Background Identification of marker genes associated with a specific tissue/cell type is a fundamental challenge in genetic and cell research. Marker genes are of great importance for determining cell identity, and for understanding tissue specific gene function and the molecular mechanisms underlying complex diseases. Results We have developed a new bioinformatics tool called MGFM (Marker Gene Finder in Microarray data) to predict marker genes from microarray gene expression data. Marker genes are identified through the grouping of samples of the same type with similar marker gene expression levels. We verified our approach using two microarray data sets from the NCBI’s Gene Expression Omn…

Genetic MarkersCancer ResearchMicroarraysBiologyMarker genesWeb BrowserProteomicsMarker geneBioconductorGeneticsGeneGenetic Association StudiesGeneticsMicroarray analysis techniquesMethodology ArticleGene Expression ProfilingComputational BiologyReproducibility of Results3. Good healthGene expression profilingSamplesGene OntologyGenetic markerOrgan SpecificityDNA microarrayBiotechnologyBMC Genomics
researchProduct